Evidence for Implementation: Management of TB in HIV and Pregnancy

Amanda J. Jones, Jyoti S. Mathad, Kelly E. Dooley, Ahizechukwu C. Eke

Research output: Contribution to journalReview articlepeer-review


Purpose of Review: Pregnant people living with HIV (PLWH) are at especially high risk for progression from latent tuberculosis infection (LTBI) to active tuberculosis (TB) disease. Among pregnant PLWH, concurrent TB increases the risk of complications such as preeclampsia, intrauterine fetal-growth restriction, low birth weight, preterm-delivery, perinatal transmission of HIV, and admission to the neonatal intensive care unit. The grave impact of superimposed TB disease on maternal morbidity and mortality among PLWH necessitates clear guidelines for concomitant therapy and an understanding of the pharmacokinetics (PK) and potential drug-drug interactions (DDIs) between antitubercular (anti-TB) agents and antiretroviral therapy (ART) in pregnancy. Recent Findings: This review discusses the currently available evidence on the use of anti-TB agents in pregnant PLWH on ART. Pharmacokinetic and safety studies of anti-TB agents during pregnancy and postpartum are limited, and available data on second-line and newer anti-TB agents used in pregnancy suggest that several research gaps exist. DDIs between ART and anti-TB agents can decrease plasma concentration of ART, with the potential for perinatal transmission of HIV. Current recommendations for the treatment of LTBI, drug-susceptible TB, and multidrug-resistant TB (MDR-TB) are derived from observational studies and case reports in pregnant PLWH. Summary: While the use of isoniazid, rifamycins, and ethambutol in pregnancy and their DDIs with various ARTs are well-characterized, there is limited data on the use of pyrazinamide and several new and second-line antitubercular drugs in pregnant PLWH. Further research into treatment outcomes, PK, and safety data for anti-TB agent use during pregnancy and postpartum is urgently needed.

Original languageEnglish (US)
Pages (from-to)455-470
Number of pages16
JournalCurrent HIV/AIDS reports
Issue number6
StatePublished - Dec 2022


  • Antiretroviral therapy
  • Antitubercular drugs
  • Pharmacokinetics
  • Pregnancy
  • Tuberculosis

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases


Dive into the research topics of 'Evidence for Implementation: Management of TB in HIV and Pregnancy'. Together they form a unique fingerprint.

Cite this